JP2023547676A5 - - Google Patents
Info
- Publication number
- JP2023547676A5 JP2023547676A5 JP2023527079A JP2023527079A JP2023547676A5 JP 2023547676 A5 JP2023547676 A5 JP 2023547676A5 JP 2023527079 A JP2023527079 A JP 2023527079A JP 2023527079 A JP2023527079 A JP 2023527079A JP 2023547676 A5 JP2023547676 A5 JP 2023547676A5
- Authority
- JP
- Japan
- Prior art keywords
- dna vector
- propionibacterium acnes
- manipulated
- phage
- vector according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063109834P | 2020-11-04 | 2020-11-04 | |
| US202063109832P | 2020-11-04 | 2020-11-04 | |
| US63/109,834 | 2020-11-04 | ||
| US63/109,832 | 2020-11-04 | ||
| US202163145969P | 2021-02-04 | 2021-02-04 | |
| US202163145967P | 2021-02-04 | 2021-02-04 | |
| US63/145,969 | 2021-02-04 | ||
| US63/145,967 | 2021-02-04 | ||
| PCT/EP2021/080667 WO2022096590A1 (en) | 2020-11-04 | 2021-11-04 | Phage-derived particles for in situ delivery of dna payload into c. acnes population |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023547676A JP2023547676A (ja) | 2023-11-13 |
| JP2023547676A5 true JP2023547676A5 (https=) | 2024-11-06 |
Family
ID=78621842
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023527081A Pending JP2023547677A (ja) | 2020-11-04 | 2021-11-04 | キューティバクテリウム・アクネス組換えファージ、その産生方法及び使用 |
| JP2023527079A Pending JP2023547676A (ja) | 2020-11-04 | 2021-11-04 | ＤＮＡペイロードをアクネ菌集団へとｉｎ ｓｉｔｕ送達するためのファージ由来粒子 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023527081A Pending JP2023547677A (ja) | 2020-11-04 | 2021-11-04 | キューティバクテリウム・アクネス組換えファージ、その産生方法及び使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (7) | US11473093B2 (https=) |
| EP (2) | EP4240841A1 (https=) |
| JP (2) | JP2023547677A (https=) |
| KR (2) | KR20230098825A (https=) |
| CA (2) | CA3198924A1 (https=) |
| IL (2) | IL302448A (https=) |
| WO (2) | WO2022096596A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
| US11844720B2 (en) | 2011-02-04 | 2023-12-19 | Seed Health, Inc. | Method and system to reduce the likelihood of dental caries and halitosis |
| US12279989B2 (en) | 2011-02-04 | 2025-04-22 | Seed Health, Inc. | Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity |
| US12257272B2 (en) | 2015-12-24 | 2025-03-25 | Seed Health, Inc. | Method and system for reducing the likelihood of developing depression in an individual |
| US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
| US12533312B2 (en) | 2011-02-04 | 2026-01-27 | Seed Health, Inc. | Method and system for preventing sore throat in humans |
| US11998479B2 (en) | 2011-02-04 | 2024-06-04 | Seed Health, Inc. | Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure |
| US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
| US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
| US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
| US11980643B2 (en) | 2013-12-20 | 2024-05-14 | Seed Health, Inc. | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection |
| US11998574B2 (en) | 2013-12-20 | 2024-06-04 | Seed Health, Inc. | Method and system for modulating an individual's skin microbiome |
| US12246043B2 (en) | 2013-12-20 | 2025-03-11 | Seed Health, Inc. | Topical application to treat acne vulgaris |
| US11969445B2 (en) | 2013-12-20 | 2024-04-30 | Seed Health, Inc. | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH |
| US12329783B2 (en) | 2013-12-20 | 2025-06-17 | Seed Health, Inc. | Method and system to improve the health of a person's skin microbiome |
| US12005085B2 (en) | 2013-12-20 | 2024-06-11 | Seed Health, Inc. | Probiotic method and composition for maintaining a healthy vaginal microbiome |
| US10760075B2 (en) | 2018-04-30 | 2020-09-01 | Snipr Biome Aps | Treating and preventing microbial infections |
| JP2023547677A (ja) | 2020-11-04 | 2023-11-13 | エリゴ・バイオサイエンス | キューティバクテリウム・アクネス組換えファージ、その産生方法及び使用 |
| US11739304B2 (en) * | 2021-05-12 | 2023-08-29 | Eligo Bioscience | Production of lytic phages |
| EP4583895A1 (en) * | 2022-09-06 | 2025-07-16 | Trobix Bio Ltd | Systems for production of transducing particles, methods, kits, compositions and uses thereof |
| WO2025089839A1 (ko) * | 2023-10-24 | 2025-05-01 | 중앙대학교 산학협력단 | Crispr-cas 탑재 박테리오파지 및 이의 용도 |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997037026A1 (en) | 1996-04-02 | 1997-10-09 | Smithkline Beecham Corporation | Novel compounds |
| JP2000512487A (ja) | 1996-05-14 | 2000-09-26 | スミスクライン・ビーチャム・コーポレイション | 新規化合物 |
| JP4469026B2 (ja) | 1996-10-31 | 2010-05-26 | ヒューマン ジノーム サイエンシーズ，インコーポレイテッド | Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｎｅｕｍｏｎｉａｅの抗原およびワクチン |
| US6800744B1 (en) | 1997-07-02 | 2004-10-05 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| CA2671261A1 (en) | 1997-11-06 | 1999-05-20 | Novartis Vaccines And Diagnostics S.R.L. | Neisserial antigens |
| EP1034277B1 (en) | 1997-11-26 | 2012-06-27 | Inhibitex, Inc. | Extracellular matrix-binding proteins from Staphylococcus aureus |
| EP1047784B2 (en) | 1998-01-14 | 2015-03-18 | Novartis Vaccines and Diagnostics S.r.l. | Neissera meningitidis antigens |
| WO1999053940A1 (en) | 1998-04-23 | 1999-10-28 | Uab Research Foundation | PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR |
| EP2261338A3 (en) | 1998-05-01 | 2012-01-04 | Novartis Vaccines and Diagnostics, Inc. | Neisseria meningitidis antigens and compositions |
| GB9810193D0 (en) | 1998-05-12 | 1998-07-08 | Smithkline Beecham Biolog | Novel compounds |
| CN1318103A (zh) | 1998-07-27 | 2001-10-17 | 微生物技术有限公司 | 肺炎链球菌的核酸和蛋白质 |
| ATE361365T1 (de) | 1998-07-27 | 2007-05-15 | Sanofi Pasteur Ltd | Streptococcus pneumoniae proteine und nukleinsäuren |
| ES2322409T3 (es) | 1998-08-31 | 2009-06-19 | Inhibitex, Inc. | Vacunas multicomponentes contra staphylococcus aureus. |
| JP4714342B2 (ja) | 1998-08-31 | 2011-06-29 | ザ プラヴアスト フエロウス アンド スカラース オブ ザ カレツヂ オブ ザ ハリー アンド アンデイヴアイデツド トリニテイ オブ クイーン エリザベス ニヤー ダブリン | コアグラーゼ陰性スタフィロコカス菌に由来のポリペプチド及びポリヌクレオチド |
| GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
| EP1140157B1 (en) | 1998-12-21 | 2009-02-18 | MedImmune, Inc. | Streptococcus pneumoniae proteins and immunogenic fragments for vaccines |
| CN1198932C (zh) | 1999-03-26 | 2005-04-27 | 科特克斯(Om)有限公司 | 肺炎链球菌抗原 |
| JP2003501110A (ja) | 1999-06-10 | 2003-01-14 | メディミューン，インコーポレーテッド | 肺炎連鎖球菌タンパク質とワクチン |
| EP1075841A1 (en) | 1999-08-13 | 2001-02-14 | Erasmus Universiteit Rotterdam | Pneumococcal vaccines |
| CA2404260A1 (en) | 2000-03-21 | 2001-09-27 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in prokaryotes |
| JP2003530872A (ja) | 2000-04-27 | 2003-10-21 | メディミューン，インコーポレイテッド | 免疫原肺炎連鎖球菌タンパク質とそのワクチン組成物 |
| JP2004502415A (ja) | 2000-07-03 | 2004-01-29 | カイロン エセ．ピー．アー． | Ｃｈｌａｍｙｄｉａｐｎｅｕｍｏｎｉａｅに対する免疫化 |
| US20040091495A1 (en) | 2000-07-20 | 2004-05-13 | Lars Bjorck | Protein |
| AU8743001A (en) | 2000-08-28 | 2002-03-13 | Aventis Pasteur | Moraxella polypeptides and corresponding dna fragments and uses thereof |
| GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
| CA2426738A1 (en) | 2000-10-26 | 2002-05-02 | David William Holden | Streptococcal genes |
| CA2881568C (en) | 2000-10-27 | 2019-09-24 | Novartis Vaccines And Diagnostics, Inc. | Nucleic acids and proteins from streptococcus groups a & b |
| AT410798B (de) | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| GB0103424D0 (en) | 2001-02-12 | 2001-03-28 | Chiron Spa | Gonococcus proteins |
| AU2002306849A1 (en) | 2001-03-21 | 2002-10-08 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in microorganisms |
| GB0107661D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
| GB0108079D0 (en) | 2001-03-30 | 2001-05-23 | Microbial Technics Ltd | Protein |
| WO2002094851A2 (en) | 2001-05-18 | 2002-11-28 | The Government Of The United States Of America, Asrepresented By The Secretary, Department Of Healthand Human Services, Centers For Disease Control And Prevention, Technology Transfer Office | Peptide vaccines against group a streptococci |
| MXPA03011701A (es) | 2001-06-15 | 2004-12-06 | Nhibitex Inc | Anticuerpos monoclonales y policlonales de reaccion que reconocen las proteinas de superficie a partir de estafilococos coagulasa-negativos y staphylococcus aureus. |
| ATE542829T1 (de) | 2001-08-02 | 2012-02-15 | Univ Sheffield | Impfstoff |
| RU2331435C2 (ru) | 2001-12-12 | 2008-08-20 | Чирон Срл. | Иммунизация против chlamydia trachomatis |
| GB0203403D0 (en) | 2002-02-13 | 2002-04-03 | Chiron Spa | Chlamydia cytotoxic-T cell epitopes |
| EP2275122A3 (en) | 2002-04-02 | 2011-05-18 | Ben Gurion University Of The Negev Research And Development Authority | Protein-based streptococcus pneumoniae vaccines |
| GB0210128D0 (en) | 2002-05-02 | 2002-06-12 | Chiron Spa | Nucleic acids and proteins from streptococcus groups A & B |
| KR20050010040A (ko) | 2002-06-11 | 2005-01-26 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 면역원성 조성물 |
| ES2504166T3 (es) | 2002-09-13 | 2014-10-08 | Novartis Vaccines And Diagnostics, Inc. | Vacuna de estreptococo del grupo B |
| ES2529736T3 (es) | 2003-04-10 | 2015-02-25 | Novartis Vaccines And Diagnostics, Inc. | Composición inmunogénica que comprende una proteína espicular del coronavirus del SARS |
| EP2311988A1 (en) | 2003-04-15 | 2011-04-20 | Intercell AG | S. pneumoniae antigens |
| MXPA05013260A (es) | 2003-06-26 | 2006-03-09 | Chiron Corp | Composiciones inmunogenicas para chlamydia trachomatis. |
| ES2505695T3 (es) | 2003-07-31 | 2014-10-10 | Novartis Vaccines And Diagnostics, Inc. | Composiciones inmunógenas para Streptococcus pyogenes |
| US20070134263A1 (en) | 2004-02-18 | 2007-06-14 | Anderson Annaliesa S | Polypeptides for inducing a protective immune response against staphyloococcus aureus |
| NZ553776A (en) | 2004-09-22 | 2010-05-28 | Glaxosmithkline Biolog Sa | Immunogenic composition comprising staphylococcal PNAG and Type 5 and/or 8 Capsular polysaccharide or oligosaccharide. |
| JP5127708B2 (ja) * | 2005-07-12 | 2013-01-23 | マイクレオス べスローテン フェンノートシャップ | バクテリオファージ及びその使用 |
| US7442511B2 (en) | 2005-12-27 | 2008-10-28 | Obetech, Llc | Adipogenic adenoviruses as a biomarker for disease |
| AU2007281934B2 (en) | 2006-01-18 | 2012-11-15 | University Of Chicago | Compositions and methods related to Staphylococcal bacterium proteins |
| WO2007116322A2 (en) | 2006-02-17 | 2007-10-18 | Novartis Ag | Purification of bacterial antigens |
| EP2476433A1 (en) | 2006-03-30 | 2012-07-18 | GlaxoSmithKline Biologicals S.A. | Immunogenic composition |
| AR060187A1 (es) | 2006-03-30 | 2008-05-28 | Glaxosmithkline Biolog Sa | Composicion inmunogenica |
| WO2014165164A2 (en) | 2013-03-12 | 2014-10-09 | Albany Medical College | Compositions and methods for treating autoimmune diseases |
| GB201600075D0 (en) | 2016-01-03 | 2016-02-17 | Glaxosmithkline Biolog Sa | Immunogenci composition |
| CN109562048A (zh) * | 2016-02-05 | 2019-04-02 | 加州大学评议会 | 用于促进皮肤健康的组合物和方法 |
| WO2017185018A1 (en) * | 2016-04-21 | 2017-10-26 | Naked Biome, Inc. | Synthetic bacteria and methods of use |
| CN109689861A (zh) * | 2016-05-15 | 2019-04-26 | 加州大学评议会 | 用于治疗痤疮的组合物和方法 |
| US20210177920A1 (en) * | 2017-12-05 | 2021-06-17 | Biomx Ltd. | Bacteriophage treatment for acne and biofilms |
| US12076352B2 (en) * | 2018-06-19 | 2024-09-03 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| WO2020181180A1 (en) | 2019-03-06 | 2020-09-10 | The Broad Institute, Inc. | A:t to c:g base editors and uses thereof |
| WO2020181178A1 (en) | 2019-03-06 | 2020-09-10 | The Broad Institute, Inc. | T:a to a:t base editing through thymine alkylation |
| WO2020181195A1 (en) | 2019-03-06 | 2020-09-10 | The Broad Institute, Inc. | T:a to a:t base editing through adenine excision |
| WO2020181202A1 (en) | 2019-03-06 | 2020-09-10 | The Broad Institute, Inc. | A:t to t:a base editing through adenine deamination and oxidation |
| WO2020181193A1 (en) | 2019-03-06 | 2020-09-10 | The Broad Institute, Inc. | T:a to a:t base editing through adenosine methylation |
| JP2023547677A (ja) | 2020-11-04 | 2023-11-13 | エリゴ・バイオサイエンス | キューティバクテリウム・アクネス組換えファージ、その産生方法及び使用 |
-
2021
- 2021-11-04 JP JP2023527081A patent/JP2023547677A/ja active Pending
- 2021-11-04 EP EP21807016.7A patent/EP4240841A1/en active Pending
- 2021-11-04 IL IL302448A patent/IL302448A/en unknown
- 2021-11-04 CA CA3198924A patent/CA3198924A1/en active Pending
- 2021-11-04 EP EP21811262.1A patent/EP4240843A1/en active Pending
- 2021-11-04 KR KR1020237018109A patent/KR20230098825A/ko active Pending
- 2021-11-04 JP JP2023527079A patent/JP2023547676A/ja active Pending
- 2021-11-04 WO PCT/EP2021/080675 patent/WO2022096596A1/en not_active Ceased
- 2021-11-04 CA CA3198876A patent/CA3198876A1/en active Pending
- 2021-11-04 IL IL302449A patent/IL302449A/en unknown
- 2021-11-04 KR KR1020237016219A patent/KR20230117105A/ko active Pending
- 2021-11-04 WO PCT/EP2021/080667 patent/WO2022096590A1/en not_active Ceased
- 2021-11-04 US US17/518,960 patent/US11473093B2/en active Active
- 2021-11-04 US US17/518,936 patent/US11820989B2/en active Active
-
2022
- 2022-08-24 US US17/821,940 patent/US11840695B2/en active Active
-
2023
- 2023-09-28 US US18/477,069 patent/US11970701B2/en active Active
- 2023-09-29 US US18/478,500 patent/US12454696B2/en active Active
-
2024
- 2024-03-27 US US18/617,782 patent/US12460216B2/en active Active
-
2025
- 2025-10-24 US US19/368,024 patent/US20260109991A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023547676A5 (https=) | ||
| JP2023547677A5 (https=) | ||
| JP7232540B2 (ja) | Ｃｒｉｓｐｒにより可能にされる多重ゲノムエンジニアリング | |
| US11530405B2 (en) | Anti-CRISPR genes and proteins and methods of use | |
| CN103382468B (zh) | 一种水稻基因组定点改造方法 | |
| JP2020511115A5 (https=) | ||
| CN103097537B (zh) | 自删除质粒 | |
| KR20180015731A (ko) | 캄필로박터 제주니 crispr/cas 시스템 유래 rgen을 이용한 유전체 교정 | |
| Karas et al. | Strategies for cloning and manipulating natural and synthetic chromosomes | |
| CN113950531A (zh) | 使用m13噬菌体优化环状单链dna | |
| JP2008533988A5 (https=) | ||
| KR20210046811A (ko) | 락토바실러스 카제이 유래의 두 종류 프로모터를 이용한 두 가지 목적단백질의 동시 표면발현벡터 및 이를 이용한 단백질의 미생물표면 발현 방법 | |
| CN105567718B (zh) | 一种同时表达多个sgRNA的载体的构建方法 | |
| EP2655620A1 (en) | Dna expression construct | |
| CN106987560A (zh) | Rk‑13细胞hb基因敲除稳定株的构建方法 | |
| Yuan et al. | A simple and efficient approach to construct mutant vaccinia virus vectors | |
| JP2021522825A5 (https=) | ||
| CN114438106B (zh) | Rv2779c基因及其表达产物作为抗结核分枝杆菌靶点的应用 | |
| JP2025503476A5 (https=) | ||
| CN112981544A (zh) | 一种sgRNA文库构建方法 | |
| JP2023531718A5 (https=) | ||
| CN119751607B (zh) | MgdE基因在调控牛分枝杆菌毒力中的应用 | |
| JP2022502081A (ja) | 遺伝子操作された微生物ならびにそれを作製および使用する方法 | |
| Beznosov et al. | Archaeal flagella as matrices for new nanomaterials | |
| Yang | TALEN and CRISPR/Cas9 for rice-genome editing |